| Monoclonal antibody; mABs, e.g. natalizumab, are produced in cell culture systems. They can be designed to bind to receptors on the body’s normal cells. By recognizing and attaching to these receptors, monoclonal antibodies can interfere with (or alter) normal or abnormal cellular response |
